ASSET PURCHASE AGREEMENT between Assertio Therapeutics, Inc., Golf Acquiror LLC and solely for the purposes set forth herein Celtic Intermediate S.A. DATED AS OF DECEMBER 11, 2019Asset Purchase Agreement • December 12th, 2019 • Assertio Therapeutics, Inc • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of December 11, 2019 (the “Effective Date”), by and between Assertio Therapeutics, Inc., Inc., a Delaware corporation (“Seller”), and Golf Acquiror LLC, a Delaware limited liability company (“Purchaser”) and, solely for the purposes of Section 6.23 and Article X, Celtic Intermediate, SA, a public limited company (société anonyme), organized and established under the laws of the Grand Duchy of Luxembourg (“Guarantor”).
SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • December 12th, 2019 • Assertio Therapeutics, Inc • Pharmaceutical preparations • New York
THIS SIXTH AMENDMENT TO NOTE PURCHASE AGREEMENT, dated as of December 11, 2019 (this “Amendment”), is entered into by and among ASSERTIO THERAPEUTICS, INC., a Delaware corporation, as successor-in-interest to DEPOMED, INC. (the “Borrower”), the other Credit Parties party hereto, the Purchasers party hereto, and DEERFIELD PRIVATE DESIGN FUND III, L.P., a Delaware limited partnership, as a Purchaser and as collateral agent (in such latter capacity, the “Agent”).
